| Authors: |
Rossi A; Vall d´Hebron Institute of Oncology, Barcelona, Spain., Braña I; Vall d´Hebron Institute of Oncology, Barcelona, Spain; Department of Medical Oncology, Vall d'Hebron Barcelona Hospital Campus, IIS IR-HUVH, Barcelona, Spain., Vieito M; Vall d´Hebron Institute of Oncology, Barcelona, Spain; Department of Medical Oncology, Vall d'Hebron Barcelona Hospital Campus, IIS IR-HUVH, Barcelona, Spain., Mirallas O; Vall d´Hebron Institute of Oncology, Barcelona, Spain; Department of Medical Oncology, Vall d'Hebron Barcelona Hospital Campus, IIS IR-HUVH, Barcelona, Spain., Navarro V; Vall d´Hebron Institute of Oncology, Barcelona, Spain., Saavedra O; Vall d´Hebron Institute of Oncology, Barcelona, Spain., Casal GA; Vall d´Hebron Institute of Oncology, Barcelona, Spain., Galvao V; Vall d´Hebron Institute of Oncology, Barcelona, Spain., Bardaji MJL; Vall d´Hebron Institute of Oncology, Barcelona, Spain; Department of Medical Oncology, Vall d'Hebron Barcelona Hospital Campus, IIS IR-HUVH, Barcelona, Spain., Oberoi A; Vall d´Hebron Institute of Oncology, Barcelona, Spain; Department of Medical Oncology, Vall d'Hebron Barcelona Hospital Campus, IIS IR-HUVH, Barcelona, Spain., Pretelli G; Vall d´Hebron Institute of Oncology, Barcelona, Spain; Department of Medical Oncology, Vall d'Hebron Barcelona Hospital Campus, IIS IR-HUVH, Barcelona, Spain., Sanz M; Vall d´Hebron Institute of Oncology, Barcelona, Spain; Department of Medical Oncology, Vall d'Hebron Barcelona Hospital Campus, IIS IR-HUVH, Barcelona, Spain., Bueno SA; Department of Medical Oncology, Vall d'Hebron Barcelona Hospital Campus, IIS IR-HUVH, Barcelona, Spain., Abril BF; Vall d´Hebron Institute of Oncology, Barcelona, Spain., Izquierdo SA; Vall d´Hebron Institute of Oncology, Barcelona, Spain., Jimenez J; Vall d´Hebron Institute of Oncology, Barcelona, Spain., Nuciforo P; Vall d´Hebron Institute of Oncology, Barcelona, Spain., Vivancos A; Vall d´Hebron Institute of Oncology, Barcelona, Spain., Oliveira M; Vall d´Hebron Institute of Oncology, Barcelona, Spain; Department of Medical Oncology, Vall d'Hebron Barcelona Hospital Campus, IIS IR-HUVH, Barcelona, Spain., Baraibar I; Vall d´Hebron Institute of Oncology, Barcelona, Spain; Department of Medical Oncology, Vall d'Hebron Barcelona Hospital Campus, IIS IR-HUVH, Barcelona, Spain., Castet F; Vall d´Hebron Institute of Oncology, Barcelona, Spain; Department of Medical Oncology, Vall d'Hebron Barcelona Hospital Campus, IIS IR-HUVH, Barcelona, Spain., Duran CG; Vall d´Hebron Institute of Oncology, Barcelona, Spain; Department of Medical Oncology, Vall d'Hebron Barcelona Hospital Campus, IIS IR-HUVH, Barcelona, Spain., Ahnert JR; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Capdevila J; Vall d´Hebron Institute of Oncology, Barcelona, Spain; Department of Medical Oncology, Vall d'Hebron Barcelona Hospital Campus, IIS IR-HUVH, Barcelona, Spain., Galceran JC; Vall d´Hebron Institute of Oncology, Barcelona, Spain; Department of Medical Oncology, Vall d'Hebron Barcelona Hospital Campus, IIS IR-HUVH, Barcelona, Spain., Macarulla T; Vall d´Hebron Institute of Oncology, Barcelona, Spain; Department of Medical Oncology, Vall d'Hebron Barcelona Hospital Campus, IIS IR-HUVH, Barcelona, Spain., Saura C; Vall d´Hebron Institute of Oncology, Barcelona, Spain; Department of Medical Oncology, Vall d'Hebron Barcelona Hospital Campus, IIS IR-HUVH, Barcelona, Spain., Felip E; Vall d´Hebron Institute of Oncology, Barcelona, Spain; Department of Medical Oncology, Vall d'Hebron Barcelona Hospital Campus, IIS IR-HUVH, Barcelona, Spain., Elez E; Vall d´Hebron Institute of Oncology, Barcelona, Spain; Department of Medical Oncology, Vall d'Hebron Barcelona Hospital Campus, IIS IR-HUVH, Barcelona, Spain., Tabernero J; Vall d´Hebron Institute of Oncology, Barcelona, Spain; Department of Medical Oncology, Vall d'Hebron Barcelona Hospital Campus, IIS IR-HUVH, Barcelona, Spain., Dienstmann R; Vall d´Hebron Institute of Oncology, Barcelona, Spain; University of Vic - Central University of Catalonia, Vic, Spain., Villacampa G; Vall d´Hebron Institute of Oncology, Barcelona, Spain., Garralda E; Vall d´Hebron Institute of Oncology, Barcelona, Spain; Department of Medical Oncology, Vall d'Hebron Barcelona Hospital Campus, IIS IR-HUVH, Barcelona, Spain., Hernando-Calvo A; Vall d´Hebron Institute of Oncology, Barcelona, Spain; Department of Medical Oncology, Vall d'Hebron Barcelona Hospital Campus, IIS IR-HUVH, Barcelona, Spain. Electronic address: albertohernando@vhio.net. |
